{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:54:55Z","timestamp":1789091695145,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd005015.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000}}],"reference-count":271,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005015.pub4","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T02:27:16Z","timestamp":1571711236000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Interventions for preventing bone disease in kidney transplant recipients"],"prefix":"10.1002","volume":"2019","author":[{"given":"Suetonia C","family":"Palmer","sequence":"first","affiliation":[{"name":"University of Otago Christchurch; Department of Medicine; 2 Riccarton Ave PO Box 4345 Christchurch New Zealand 8140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund YM","family":"Chung","sequence":"additional","affiliation":[{"name":"Royal North Shore Hospital; Department of Medicine; 48 Provincial Road Sydney NSW Australia 2070"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O","family":"McGregor","sequence":"additional","affiliation":[{"name":"Christchurch Hospital; Department of Nephrology; Private Bag 4710 Christchurch New Zealand 8001"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Bachmann","sequence":"additional","affiliation":[{"name":"Charit\u00e9 University Medicine Berlin; Department of Nephrology and Medical Intensive Care; Charit\u00e9platz 1 Berlin Germany 10117"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni FM","family":"Strippoli","sequence":"additional","affiliation":[{"name":"University of Bari; Department of Emergency and Organ Transplantation; Bari Italy"},{"name":"Diaverum; Medical Scientific Office; Lund Sweden"},{"name":"Diaverum Academy; Bari Italy"},{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"issue":"Suppl S3","key":"10.1002\/14651858.CD005015.pub4-BIB0001|cit1","first-page":"452","article-title":"Oral paricalcitol in kidney transplant recipients receiving a corticosteroid-free immunosuppressive regimen: an open label randomized trial [abstract no: LB33]","volume":"12","author":"Amer","year":"2012","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005015.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00007890-201407151-03012","article-title":"Effects of paricalcitol on bone turnover in kidney transplant recipients [abstract no: A39]","volume":"98","author":"Amer","year":"2014","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/ajt.12227","article-title":"Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial","volume":"13","author":"Amer","year":"2013","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005015.pub4-BIB0004|cit4","first-page":"185","article-title":"Proteinuria in kidney transplant recipients: prevalence in a national cohort and study design of the effect of paricalcitol for reduction of proteinuria [abstract no: RO-204]","volume":"24","author":"Arnol","year":"2011","journal-title":"Transplant International"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD005015.pub4-BIB0005|cit5","first-page":"S214","article-title":"Paricalcitol versus placebo for reduction of proteinuria in kidney transplant recipients: a double-blind, randomized controlled trial [abstract no: 426.4]","volume":"100","author":"Arnol","year":"2016","journal-title":"Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD005015.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1600-6143.2008.02327.x","article-title":"Effect of teriparatide on early bone loss after kidney transplantation","volume":"8","author":"Cejka","year":"2008","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0007|cit7","unstructured":"Chalopin JM Garnier PC D'Athis P Cabanne JF Perceau C Tanter Y Vitamin D3 metabolites and mineral metabolism parameters after renal transplantation: prospective randomized study with 250H vitamin D3 therapy [abstract] 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK 1987 418"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0008|cit8","first-page":"927A","article-title":"Randomized trial of IV pamidronate to ameliorate bone loss in renal transplant (RT) recipients [abstract]","volume":"12","author":"Coco","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0009|cit9","first-page":"10A","article-title":"Prospective randomised trial of IV pamidronate in renal transplant recipients: 6 and 12 month follow-up [abstract no: F-FC044]","volume":"13","author":"Coco","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Sept","key":"10.1002\/14651858.CD005015.pub4-BIB0010|cit10","first-page":"561A","article-title":"Effect of IV pamidronate on bone biochemical parameters in renal transplant recipients [abstract]","volume":"11","author":"Coco","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD005015.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/01.ASN.0000087092.53894.80","article-title":"Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate","volume":"14","author":"Coco","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Nov","key":"10.1002\/14651858.CD005015.pub4-BIB0012|cit12","first-page":"695A","article-title":"Pamidronate used to ameliorate post renal transplant bone loss is not associated with increased renal dysfunction [abstract no: SU-PO729]","volume":"14","author":"Lee","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD005015.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1093\/ndt\/gfh504","article-title":"Pamidronate used to attenuate post-renal transplant bone loss is not associated with renal dysfunction","volume":"19","author":"Lee","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Abstracts","key":"10.1002\/14651858.CD005015.pub4-BIB0014|cit14","first-page":"302A","article-title":"Prophylactic risedronate in new renal transplant recipients: effects on serial bone mineral density and bone histology [abstract no: F-PO909]","volume":"18","author":"Coco","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD005015.pub4-BIB0015|cit15","first-page":"759A","article-title":"Randomized controlled trial of risedronate in renal transplant recipients: histomorphometry shows lowered bone turnover but not adynamic bone [Abstract no: SA-PO2830]","volume":"20","author":"Coco","year":"2009","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1681\/ASN.2011060623","article-title":"Effect of risedronate on bone in renal transplant recipients","volume":"23","author":"Coco","year":"2012","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005015.pub4-BIB0017|cit17","article-title":"A randomized study comparing parathyroidectomy versus cinacalcet to treat hypercalcemia in kidney allograft recipients with persistent hyperparathyroidism [abstract no: 756]","volume":"15","author":"Cruzado","year":"2015","journal-title":"American Journal of Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2015060622","article-title":"A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism","volume":"27","author":"Cruzado","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005015.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"iii36","DOI":"10.1093\/ndt\/gfv151.01","article-title":"A randomized study comparing parathyroidectomy versus cinacalcet to treat hypercalcemia in kidney allograft recipients with persistent hyperparathyroidism [abstract]","volume":"30","author":"Cruzado","year":"2015","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0272-6386(00)70331-3","article-title":"Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation","volume":"35","author":"Cueto-Manzano","year":"2000","journal-title":"American Journal of Kidney Diseases"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0021|cit21","first-page":"929A","article-title":"Prophylaxis of bone loss after renal transplantation with calcium and vitamin D [abstract no: A4855]","volume":"12","author":"Sevaux","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/01.ASN.0000016082.70875.36","article-title":"Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study","volume":"13","author":"Sevaux","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005015.pub4-BIB0023|cit23","first-page":"259","article-title":"A prospective study for prevention of post transplantation bone loss in renal transplant recipients [abstract no: P-662]","volume":"22","author":"Dovas","year":"2009","journal-title":"Transplant International"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005015.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF02500711","article-title":"Bone loss after renal transplantation: HRT versus calcitriol in postmenopausal recipients [abstract no: PTu844]","volume":"6","author":"Eid","year":"1996","journal-title":"Osteoporosis International"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005015.pub4-BIB0025|cit25","first-page":"249","article-title":"Prevention of osteoporosis after kidney transplantation: a prospective randomized study [abstract no: M777]","volume":"18","author":"El-Agroudy","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD005015.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1097\/01.ASN.0000093255.56474.B4","article-title":"Preventing bone loss in renal transplant recipients with vitamin D","volume":"14","author":"El-Agroudy","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1523-1755.2005.00306.x","article-title":"A prospective randomized study for prevention of postrenal transplantation bone loss","volume":"67","author":"El-Agroudy","year":"2005","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0028|cit28","unstructured":"El Husseini A Elagroudy A Elsayed M Sobh M Ghoneim M Treatment of bone loss with vitamin D in live related kidney transplant children and adolescents: a prospective randomized study [abstract no: SP231] 41st Congress European Renal Association European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal 2004 93"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005015.pub4-BIB0029|cit29","first-page":"544","article-title":"Treatment of bone loss in renal transplant children and adolescents [abstract no: T818]","volume":"18","author":"El-Husseini","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD005015.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/j.1600-6143.2004.00618.x","article-title":"A prospective randomized study for the treatment of bone loss with vitamin D during kidney transplantation in children and adolescents","volume":"4","author":"El-Husseini","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005015.pub4-BIB0031|cit31","first-page":"v80","article-title":"A prospective randomized study for the treatment of bone loss with alendronate in kidney transplant children and adolescents [abstract no: SP181]","volume":"20","author":"El-Husseini","year":"2005","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD005015.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1399-3046.2004.00191.x","article-title":"Treatment of osteopenia and osteoporosis in renal transplant children and adolescents","volume":"8","author":"El-Husseini","year":"2004","journal-title":"Pediatric Transplantation"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005015.pub4-BIB0033|cit33","first-page":"v361","article-title":"Alfacalcidol versus calcitonin for the treatment of bone loss after renal transplantation in children and adolescents [abstract no: MP482]","volume":"20","author":"El-Husseini","year":"2005","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD005015.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/ajt.12911","article-title":"A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism","volume":"14","author":"Evenepoel","year":"2014","journal-title":"American Journal of Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0035|cit35","first-page":"1789","article-title":"Randomized prospective study demonstrating prevention of bone loss by pamidronate during the first year after renal transplantation [abstract no: A2714]","volume":"7","author":"Fan","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0036|cit36","first-page":"684","article-title":"Pamidronate therapy as prevention of bone loss following renal transplantation","volume":"57","author":"Fan","year":"2000","journal-title":"Kidney International"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1046\/j.1523-1755.2003.00012.x","article-title":"Long-term effects on bone mineral density of pamidronate given at the time of renal transplantation","volume":"63","author":"Fan","year":"2003","journal-title":"Kidney International"},{"issue":"Abstracts","key":"10.1002\/14651858.CD005015.pub4-BIB0038|cit38","first-page":"132A","article-title":"Oral risedronate is a successful treatment for bone loss in the long-term kidney transplant patients [abstract no: TH-PO123]","volume":"17","author":"Fujii","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0039|cit39","unstructured":"Carraro G Perin N Giannini S Naso A Legnaro A D'Angelo A Alendronate prevents further bone loss in renal transplant recipients [abstract no: 448] 10th ESOT & 12th ETCO Congress. Bridging the Future; 2001 Oct 6-11; Lisbon, Portugal 2001"},{"issue":"11","key":"10.1002\/14651858.CD005015.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1359\/jbmr.2001.16.11.2111","article-title":"Alendronate prevents further bone loss in renal transplant recipients","volume":"16","author":"Giannini","year":"2001","journal-title":"Journal of Bone & Mineral Research"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/00007890-199810270-00007","article-title":"Treatment of osteopenia and osteoporosis after kidney transplantation","volume":"66","author":"Grotz","year":"1998","journal-title":"Transplantation"},{"issue":"Abstracts Issue","key":"10.1002\/14651858.CD005015.pub4-BIB0042|cit42","first-page":"679A","article-title":"Early ibandronate administration improves long-term renal allograft function [abstract no: SA-PO2533]","volume":"19","author":"Gerke","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD005015.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1681\/ASN.V1271530","article-title":"Effect of ibandronate on bone loss and renal function after kidney transplantation","volume":"12","author":"Grotz","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1046\/j.1523-1755.2003.00816.x","article-title":"Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation","volume":"63","author":"Haas","year":"2003","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1523-1755.2004.00369.x","article-title":"Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation","volume":"65","author":"Schwarz","year":"2004","journal-title":"Kidney International"},{"issue":"Nov","key":"10.1002\/14651858.CD005015.pub4-BIB0046|cit46","first-page":"697A","article-title":"Non-sustained effect of short term bisphsophonate therapy on bone turnover three years after renal transplantation [abstract no: SU-PO736]","volume":"14","author":"Schwarz","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005015.pub4-BIB0047|cit47","first-page":"353","article-title":"A randomized prospective trial of calcitriol versus alendronate for the treatment of osteopenia in renal transplant recipients [abstract]","volume":"3","author":"Jeffery","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD005015.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/01.TP.0000092523.30277.13","article-title":"Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate","volume":"76","author":"Jeffery","year":"2003","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005015.pub4-BIB0049|cit49","first-page":"124","article-title":"Cholecalciferol for prevention of chronic allograft nephropathy, kidney repair, and management of cardiorenal syndrome in vitamin D insufficient kidney transplant recipients [abstract]","volume":"15","author":"Kharlamov","year":"2010","journal-title":"European Journal of Medical Research"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0050|cit50","first-page":"33","article-title":"Vitamin D in the treatment of cardiorenal syndrome in patients with chronic nephropathy","volume":"52","author":"Kharlamov","year":"2012","journal-title":"Kardiologiia"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0041-1345(02)02872-5","article-title":"Alendronate increases bone mineral density in long-term renal transplant recipients","volume":"34","author":"Koc","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0052|cit52","first-page":"A227","article-title":"Alendronate increases bone mineral density in renal transplant recipients [abstract]","volume":"16","author":"Koc","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD005015.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1016\/j.transproceed.2008.09.034","article-title":"Alendronate is effective to treat bone loss in renal transplantation recipients","volume":"40","author":"Lan","year":"2008","journal-title":"Transplantation Proceedings"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0054|cit54","first-page":"937","article-title":"Prevention of bone loss following kidney transplantation with alendronate: a randomized controlled study [abstract no: A4897]","volume":"12","author":"Lord","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005015.pub4-BIB0055|cit55","first-page":"518","article-title":"Cholecalciferol supplements in renal transplant recipients with vitamin D deficiency [abstract no: 1688]","volume":"10","author":"Marc\u00e9n","year":"2010","journal-title":"American Journal of Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0056|cit56","first-page":"622A","article-title":"Calcitriol and VDR genotype influences on bone mineral density after renal transplantation [abstract no: A3149]","volume":"10","author":"Messa","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0057|cit57","first-page":"941A","article-title":"One year controlled trial of pamidronate in the treatment of severe osteopenia after long term renal transplantation (TX) [abstract no: A4914]","volume":"12","author":"Montilla","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005015.pub4-BIB0058|cit58","first-page":"235","article-title":"The effects of bisphosphonates to prevent GIOP in kidney transplantation recipients. The tentative report of single-blind randomized prospective clinical study [abstract no: P-568]","volume":"22","author":"Nakamura","year":"2009","journal-title":"Transplant International"},{"issue":"7","key":"10.1002\/14651858.CD005015.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0041-1345(00)01898-4","article-title":"Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation","volume":"32","author":"Nam","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005015.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00007890-201407151-00390","article-title":"Reduction of proteinuria with selective vitamin D receptor activation using paricalcitol in renal transplant patients [abstract no: 2244]","volume":"98","author":"Narasimhamurthy","year":"2014","journal-title":"Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.transproceed.2007.01.065","article-title":"Effect of bisphosphonates on bone mineral density after renal transplantation as assessed by bone mineral densitometry","volume":"39","author":"Nayak","year":"2007","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01769669","article-title":"Bone mineral content after renal transplantation. Placebo-controlled prospective study with 1,25-dihydroxy vitamin D3","volume":"62","author":"Neubauer","year":"1984","journal-title":"Klinische Wochenschrift"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0063|cit63","first-page":"1212","article-title":"The effect of nasal calcitonin on bone mineral density in renal transplant recipients [abstract]","volume":"11","author":"Nordal","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0064|cit64","first-page":"1109","article-title":"Nasal calcitonin reduces bone loss in renal transplant recipients [abstract]","volume":"6","author":"Nordal","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0065|cit65","first-page":"269613","article-title":"Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients","author":"Okamoto","year":"2014","journal-title":"Journal of Transplantation"},{"issue":"10 Suppl","key":"10.1002\/14651858.CD005015.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/00007890-201211271-01768","article-title":"Oral paricalcitol versus oral calcitriol for the treatment of secondary hyperparathyroidism in renal transplantation [abstract no: 1707]","volume":"94","author":"Oliden","year":"2012","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0067|cit67","first-page":"420","article-title":"Comparison of alendronate and pamidronate on bone loss in kidney transplant patients for the first 6 months of transplantation. [Erratum appears in Iran J Kidney Dis. 2012 Jul;6(4):321]","volume":"5","author":"Omidvar","year":"2011","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005015.pub4-BIB0068|cit68","first-page":"170","article-title":"Comparison the effect of alendronate and pamidronate on early BMD changes in kidney transplant patients in the first 6 months of transplantation [abstract no: 0740]","volume":"13","author":"Omidvar","year":"2010","journal-title":"International Journal of Rheumatic Diseases"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005015.pub4-BIB0069|cit69","first-page":"iii400","article-title":"Cinacalcet (CM) vs paricalcitol (PC) in renal transplant (TX) patients with hypercalcemic persisting secondary hyperparathyroidism (HPSH) a pilot study (EudraCT 2010-021041-42) [abstract no: MP219]","volume":"29","author":"Pasquali","year":"2014","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 12","key":"10.1002\/14651858.CD005015.pub4-BIB0070|cit70","first-page":"6","article-title":"Alfa-calcidol protects against spinal bone loss after cadaveric renal transplantation: a randomised placebo-controlled trial [abstract no: O14]","volume":"17","author":"Peeters","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0071|cit71","first-page":"943A","article-title":"Alfa-calcidol protects against spinal bone loss after renal transplantation: a randomised placebo controlled trial [abstract no: A4925]","volume":"12","author":"Peeters","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.transproceed.2010.07.077","article-title":"Effect of paricalcitol on the urinary peptidome of kidney transplant patients","volume":"42","author":"Perez","year":"2010","journal-title":"Transplantation Proceedings"},{"issue":"1-3","key":"10.1002\/14651858.CD005015.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2013.03.040","article-title":"Magnetic bead-based proteomic technology to study paricalcitol effect in kidney transplant recipients","volume":"709","author":"Perez","year":"2013","journal-title":"European Journal of Pharmacology"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0076|cit74","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/tri.12973","article-title":"Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study","volume":"30","author":"Pihlstrom","year":"2017","journal-title":"Transplant International"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005015.pub4-BIB0074|cit75","first-page":"815","article-title":"Paricalcitol for prevention and reduction of albuminuria in the general renal transplant recipient [abstract no: P767]","volume":"28","author":"Pihlstr\u00f8m","year":"2015","journal-title":"Transplant International"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005015.pub4-BIB0075|cit76","first-page":"760","article-title":"Early introduction of oral paricalcitol in renal transplant recipients. an open-label randomized study [abstract no: D149]","volume":"17","author":"Pihlstr\u00f8m","year":"2017","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005015.pub4-BIB0077|cit77","first-page":"ii304","article-title":"A randomized open-label clinical trial examining the effect of denosumab on the prevention of 1st-year bone mineral density loss after renal transplantation (POSTOP study; NCT01377467) [abstract]","volume":"27","author":"Bonani","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 208","key":"10.1002\/14651858.CD005015.pub4-BIB0078|cit78","first-page":"24S","article-title":"Prevention of bone mineral density (BMD) loss after kidney transplantation with the rank ligand inhibitor denosumab (POSTOP study): Baseline data, biomarker response and initial safety [abstract no: P47]","volume":"144","author":"Bonani","year":"2014","journal-title":"Swiss Medical Weekly"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/ajt.13692","article-title":"Effect of twice-yearly denosumab on prevention of bone mineral density loss in de novo kidney transplant recipients: a randomized controlled trial","volume":"16","author":"Bonani","year":"2016","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005015.pub4-BIB0080|cit80","first-page":"323","article-title":"Denosumab prevents bone mineral density loss in de novo kidney transplant recipients: results from a randomized controlled trial [abstract]","volume":"16","author":"Bonani","year":"2016","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005015.pub4-BIB0081|cit81","first-page":"580","article-title":"Infections in de novo kidney transplant recipients treated with the RANKL inhibitor denosumab: a post-hoc analysis of the POSTOP clinical trial (NCT01377467) [abstract]","volume":"16","author":"Bonani","year":"2016","journal-title":"American Journal of Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD005015.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1097\/TP.0000000000001547","article-title":"Infections in de novo kidney transplant recipients treated with the RANKL inhibitor denosumab","volume":"101","author":"Bonani","year":"2016","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1159\/000447930","article-title":"Effect of denosumab on peripheral compartmental bone density, microarchitecture and estimated bone strength in de novo kidney transplant recipients","volume":"41","author":"Bonani","year":"2016","journal-title":"Kidney & Blood Pressure Research"},{"issue":"4","key":"10.1002\/14651858.CD005015.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000355781","article-title":"Sclerostin blood levels before and after kidney transplantation","volume":"39","author":"Bonani","year":"2014","journal-title":"Kidney & Blood Pressure Research"},{"issue":"Suppl 105","key":"10.1002\/14651858.CD005015.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-201211271-01745","article-title":"A randomized open-label clinical trial examining the effect of denosumab on the prevention of first-year bone mineral density loss after renal transplantation (postop study; NCT01377467) [abstract]","volume":"94","author":"Bonani","year":"2012","journal-title":"Transplantation"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD005015.pub4-BIB0086|cit86","first-page":"S215","article-title":"Effect of the RANKL inhibitor denosumab on early loss of bone mineral density and skeletal microstructure in first-year kidney transplant recipients [abstract]","volume":"100","author":"Wuthrich","year":"2016","journal-title":"Transplantation"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD005015.pub4-BIB0087|cit87","first-page":"247A","article-title":"Effect of RANK ligand inhibition with denosumab on CKD-MBD parameters in de novo renal transplant recipients [abstract no: TH-PO613]","volume":"25","author":"Wuthrich","year":"2014","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD005015.pub4-BIB0088|cit88","first-page":"B2","article-title":"Prevention of bone mineral density loss in de novo kidney transplant recipients with twice-yearly denosumab: a randomized controlled trial (clinicaltrials.gov number NCT01377467 [abstract no: HI-OR06]","volume":"26","author":"Wuthrich","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD005015.pub4-BIB0089|cit89","first-page":"905","article-title":"Effect of denosumab on trabecular bone score (TBS) in de novo kidney transplant recipients (KTR) [abstract no: SA-PO654]","volume":"29","author":"Wuthrich","year":"2018","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005015.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00007890-201407151-01775","article-title":"UVB exposure increases serum calcidiol level in vitamin D deficiency kidney transplantation recipients [abstract no: B931]","volume":"98","author":"Praditpornsilpa","year":"2014","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0091|cit91","unstructured":"Psimenou E Konstantinidou E Giapraka N Marinaki S Kostakis A Stathakis CP Randomised controlled study of calcitonin and etidronate in the treatment of osteoporosis in renal transplant patients [abstract no: 2316] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami, USA 2002"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/MNM.0000000000000316","article-title":"Monthly ibandronate versus weekly risedronate treatment for low bone mineral density in stable renal transplant patients","volume":"36","author":"Sanchez-Escuredo","year":"2015","journal-title":"Nuclear Medicine Communications"},{"issue":"197","key":"10.1002\/14651858.CD005015.pub4-BIB0093|cit93","article-title":"Comparison between the effects of calcitriol and cholecalciferol on bone mineral density of renal transplant patients [abstract]","volume":"30","author":"Shahidi","year":"2012","journal-title":"Journal of Isfahan Medical School"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005015.pub4-BIB0094|cit94","first-page":"4","article-title":"Comparison between the effects of calcitriol and cholecalciferol on bone mineral density of renal transplant patients [abstract]","volume":"5","author":"Shahidi","year":"2011","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0095|cit95","first-page":"50","article-title":"Low-dose pamidronate for treatment of early bone loss following kidney transplantation: a randomized controlled trial","volume":"9","author":"Shahidi","year":"2015","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005015.pub4-BIB0097|cit96","first-page":"A96","article-title":"Effect of alendronate on post renal transplant osteoporosis: a randomised study [abstract no: M-PO50059]","volume":"10","author":"Sharma","year":"2005","journal-title":"Nephrology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD005015.pub4-BIB0096|cit97","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00007890-200407271-00166","article-title":"Effect of alendronate of post renal transplant osteoporosis: a randomised study [abstract no: O153]","volume":"78","author":"Sharma","year":"2004","journal-title":"Transplantation"},{"issue":"Nov","key":"10.1002\/14651858.CD005015.pub4-BIB0099|cit98","first-page":"652A","article-title":"Effect of alendronate on post renal transplant osteoporosis: a randomized study [abstract no: SU-PO544]","volume":"14","author":"Sharma","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD005015.pub4-BIB0098|cit99","first-page":"236","article-title":"Role of alendronate in post renal transplant osteoporosis: a randomised study [abstract]","volume":"12","author":"Sharma","year":"2002","journal-title":"Indian Journal of Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005015.pub4-BIB0100|cit100","first-page":"249","article-title":"Role of alendronate on post renal transplant osteoporosis: a randomised study [abstract no: M775]","volume":"18","author":"Sharma","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD005015.pub4-BIB0101|cit101","first-page":"836A","article-title":"Is pamidronate more effective than alendronate in adult patients for the prevention of bone loss after kidney transplantation? [abstract no: PUB116]","volume":"21","author":"Sirsat","year":"2010","journal-title":"Journal of the American Society of Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD005015.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"e13131","DOI":"10.1111\/ctr.13131","article-title":"A rapid and sustained improvement of calcification propensity score (serum T50) after successful kidney transplantation: reanalysis of a randomized controlled trial of ibandronate","volume":"31","author":"Smerud","year":"2017","journal-title":"Clinical Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD005015.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1111\/j.1600-6143.2012.04233.x","article-title":"A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation","volume":"12","author":"Smerud","year":"2012","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005015.pub4-BIB0104|cit104","first-page":"40","article-title":"A one year prospective, randomised, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation [abstract no: O-144]","volume":"24","author":"Smerud","year":"2011","journal-title":"Transplant International"},{"issue":"9","key":"10.1002\/14651858.CD005015.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2215\/CJN.01100112","article-title":"Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone quality","volume":"7","author":"Starke","year":"2012","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0106|cit106","first-page":"3485","article-title":"Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients","volume":"28","author":"Talalaj","year":"1996","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005015.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.tp.0000332078.07013.e0","article-title":"Prospective evaluation of the risk benefit ratio of a vitamin D treatment during the early period after renal transplantation [abstract no: 697]","volume":"86","author":"Thervet","year":"2008","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005015.pub4-BIB0108|cit108","first-page":"462","article-title":"Vitamin D receptor activation with calcitriol reduce urinary angiotensinogen A marker of intrarenal renin angiotensin system correlates with albuminuria in patients with hypertensive chronic renal allograft nephropathy [abstract no: P275]","volume":"28","author":"Tiryaki","year":"2015","journal-title":"Transplant International"},{"issue":"4","key":"10.1002\/14651858.CD005015.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0041-1345(03)00479-2","article-title":"Alendronate for treatment of renal transplant patients with osteoporosis","volume":"35","author":"Torregrosa","year":"2003","journal-title":"Transplantation Proceedings"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1432-2277.2007.00501.x","article-title":"Weekly risedronate in kidney transplant patients with osteopenia","volume":"20","author":"Torregrosa","year":"2007","journal-title":"Transplant International"},{"issue":"12","key":"10.1002\/14651858.CD005015.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1097\/TP.0b013e3181dc13d0","article-title":"Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipients","volume":"89","author":"Torregrosa","year":"2010","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0112|cit112","unstructured":"Torregrosa JV Gentil MA Marcen R Zarraga S Bravo J Guirado L Open-label trial: weekly risedronate immediately after transplantation in kidney recipients with osteopenia and vascular calcification [abstract no: M728] World Congress of Nephrology; 2009 May 22-26; Milan, Italy 2009"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00198-010-1197-2","article-title":"Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant","volume":"22","author":"Torregrosa","year":"2011","journal-title":"Osteoporosis International"},{"issue":"Sept","key":"10.1002\/14651858.CD005015.pub4-BIB0114|cit114","first-page":"575A","article-title":"Oral calcitriol prevents early bone loss after renal transplantation (RT): double blind placebo controlled study [abstract no: 3036]","volume":"11","author":"Garcia","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1523-1755.2004.00432.x","article-title":"Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation","volume":"65","author":"Torres","year":"2004","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.transproceed.2007.12.001","article-title":"Treatment of renal transplant recipients with low bone mineral density: a randomized prospective trial of alendronate, alfacalcidol, and alendronate combined with alfacalcidol","volume":"40","author":"Trabulus","year":"2008","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.2013111185","article-title":"Paricalcitol for secondary hyperparathyroidism in renal transplantation","volume":"26","author":"Trillini","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD005015.pub4-BIB0118|cit118","first-page":"850A","article-title":"Oral paricalcitol ameliorates post-transplant hyperparathyroidism and proteinuria in kidney transplantation [abstract no: SA-PO975]","volume":"24","author":"Trillini","year":"2013","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0041-1345(00)00888-5","article-title":"Efficiency of preventive treatment for osteoporosis after renal transplantation","volume":"32","author":"U\u011fur","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"Abstracts","key":"10.1002\/14651858.CD005015.pub4-BIB0120|cit120","first-page":"131A","article-title":"Effect of pamidronate (aredia) on bone loss and fracture after renal transplantation [abstract no: TH-PO121]","volume":"17","author":"Cunningham","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.ajkd.2008.11.036","article-title":"Effect of pamidronate on bone loss after kidney transplantation: a randomized trial","volume":"53","author":"Walsh","year":"2009","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.TP.0000149322.70295.A5","article-title":"A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids","volume":"79","author":"Wissing","year":"2005","journal-title":"Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0123|cit123","first-page":"952A","article-title":"A prospective and randomized study of calcium and cholecalciferol treatment to prevent bone loss after renal transplantation [abstract]","volume":"12","author":"Wissing","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0272-6386(99)70045-4","article-title":"Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid\/base homeostasis","volume":"34","author":"Ambuhl","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD005015.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.transproceed.2007.04.012","article-title":"Calcitriol started in the donor, expands the population of CD4+CD25+ T cells in renal transplant recipients","volume":"39","author":"Ardalan","year":"2007","journal-title":"Transplantation Proceedings"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0126|cit126","first-page":"754A","article-title":"Influence of immunosuppressive treatment on markers of bone remodeling in renal transplantation: comparison between cyclosporine and sirolimus [abstract]","volume":"10","author":"Campistol","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8 Suppl","key":"10.1002\/14651858.CD005015.pub4-BIB0127|cit127","first-page":"S289","article-title":"Sirolimus (rapamune): effects on bone in renal transplant patients [abstract]","volume":"69","author":"Campistol","year":"2000","journal-title":"Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0128|cit128","first-page":"886A","article-title":"Changes in bone mineral density (BMD) in kidney transplant recipients receiving tacrolimus (FK506) versus cyclosporine (Cy-A) [abstract no: A4637]","volume":"12","author":"El-Haggan","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0041-1345(02)03094-4","article-title":"One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine","volume":"34","author":"El-Haggan","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005015.pub4-BIB0130|cit130","first-page":"681","article-title":"Thoracic vertebral bone density increases with Renagel and decreases with calcium-based phosphate binder therapy - a two year study [abstract no: W423]","volume":"18","author":"James","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0131|cit131","first-page":"759A","article-title":"Post-transplant osteopenia [abstract]","volume":"10","author":"Josephson","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0132|cit132","first-page":"720A","article-title":"Calcium and calcitriol prophylaxis against post-transplant bone loss [abstract]","volume":"11","author":"Josephson","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.TP.0000137937.44703.42","article-title":"Calcium and calcitriol prophylaxis attenuates posttransplant bone loss","volume":"78","author":"Josephson","year":"2004","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0134|cit134","unstructured":"Labib B Ibrahim MA El Shawarby M Abudl Rahman A Abdel Wahab M Elagroudy A Effect of calculation therapy on renal osteodystrophy [abstract] XXXVI Congress of the European Renal Association European Dialysis & Transplant Association; 1999 Sep 5-8; Madrid, Spain 1999 42"},{"issue":"12","key":"10.1002\/14651858.CD005015.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1097\/00007890-199806270-00439","article-title":"A randomized, double-blind, multi-center trial comparing two corticosteroid regimens in combination with mycophenolate mofetil (MMF) and cyslosporine (CYA) in renal transplant recipients [abstract no: 420]","volume":"65","author":"Hene","year":"1998","journal-title":"Transplantation"},{"issue":"1-2","key":"10.1002\/14651858.CD005015.pub4-BIB0137|cit136","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0041-1345(98)01522-X","article-title":"Comparison of two corticosteroid regimens in combination with CellCept and cyclosporine A for prevention of acute allograft rejection: 12 month results of a double-blind, randomized, multi-center study. M 55002 Study Group","volume":"31","author":"Lebranchu","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0136|cit137","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0041-1345(99)00992-6","article-title":"Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group","volume":"32","author":"Lebranchu","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"7","key":"10.1002\/14651858.CD005015.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1097\/00007890-199904150-00956","article-title":"A comparison of two corticosteroid regimens in kidney transplanted patients treated with ATG\/OKT3 induction, mycophenolate mofetil (MMF) and cyclosporine A (CyA) for prevention of acute allograft rejection. 12 months results of a double-blind, randomized, multi-center study [abstract no: 932]","volume":"67","author":"Lebranchu","year":"1999","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0041-1345(01)02847-0","article-title":"Elevated serum immunoglobulins after steroid withdrawal in renal allograft recipients","volume":"34","author":"Nowacka-Cieciura","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0041-1345(01)02846-9","article-title":"Steroid withdrawal after renal transplantation--risks and benefits","volume":"34","author":"Nowacka-Cieciura","year":"2002","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0141|cit141","doi-asserted-by":"crossref","unstructured":"Nowacka-Cieciura E Durlik M Cieciura T TaLaLaj M KukuLa K Lewadowska D Positive effect of steroid withdrawal on bone mineral density in renal allograft recipients [abstract no: P0568W] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome, Italy 2000","DOI":"10.1016\/S0041-1345(00)02475-1"},{"issue":"1-2","key":"10.1002\/14651858.CD005015.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0041-1345(00)02475-1","article-title":"Positive effect of steroid withdrawal on bone mineral density in renal allograft recipients","volume":"33","author":"Nowacka-Cieciura","year":"2001","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0143|cit143","doi-asserted-by":"crossref","unstructured":"Nowacka-Cieciura E Durlik M Cieciura T Talalaj M Kukula K Lewadowska D Positive effect of steroid withdrawal on bone mineral density in renal allograft recipients [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27 Sep 1; Rome, Italy 2000","DOI":"10.1016\/S0041-1345(00)02475-1"},{"issue":"1-2","key":"10.1002\/14651858.CD005015.pub4-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0041-1345(00)02475-1","article-title":"Positive effect of steroid withdrawal on bone mineral density in renal allograft recipients","volume":"33","author":"Nowacka-Cieciura","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0041-1345(00)01251-3","article-title":"Effect of glucocorticoid-free immunosuppressive protocol on serum lipids in renal transplant patients","volume":"32","author":"Nowacka-Cieciura","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/S0041-1345(99)00327-9","article-title":"Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish Group. Spanish Group of the CellCept Study","volume":"31","author":"Puig","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD005015.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/00007890-200011150-00015","article-title":"Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection","volume":"70","author":"Vanrenterghem","year":"2000","journal-title":"Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD005015.pub4-BIB0148|cit148","first-page":"207","article-title":"Effect of disodium monofluorophosphate, calcium and vitamin D supplementation on bone mineral density in patients chronically treated with glucocorticosteroids: a prospective, randomized, double-blind study","volume":"22","author":"Lippuner","year":"1996","journal-title":"Mineral & Electrolyte Metabolism"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0149|cit149","first-page":"692A","article-title":"Glucocorticosteroids (GC) early after kidney transplantation (KT): beneficial effect of deflazacort (DFZ) versus prednisone (PRED) on bone and body composition in a double blind study [abstract no: A3223]","volume":"8","author":"Lippuner","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD005015.pub4-BIB0150|cit150","first-page":"3795","article-title":"Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: a randomized, double blind study in kidney transplant patients","volume":"83","author":"Lippuner","year":"1998","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"1-2","key":"10.1002\/14651858.CD005015.pub4-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0041-1345(00)02390-3","article-title":"Initial bone loss in kidney transplant recipients: a prospective study","volume":"33","author":"Masse","year":"2001","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0152|cit152","unstructured":"Raggi P Guasch A Mineral metabolism and vascular effects of Vitamin D therapy in kidney www.clinicaltrials.gov\/ct2\/show\/NCT00646282"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00007890-199702150-00009","article-title":"Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: a prospective study","volume":"63","author":"Aroldi","year":"1997","journal-title":"Transplantation"},{"issue":"9268","key":"10.1002\/14651858.CD005015.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(00)04766-8","article-title":"Osteoporosis after organ transplantation","volume":"357","author":"Goffin","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0272-6386(00)70051-5","article-title":"Long-term results with cyclosporine monotherapy in renal transplant patients: a multivariate analysis of risk factors","volume":"35","author":"Montagnino","year":"2000","journal-title":"American Journal of Kidney Diseases"},{"issue":"10","key":"10.1002\/14651858.CD005015.pub4-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1681\/ASN.V12102163","article-title":"Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation","volume":"12","author":"Montagnino","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0161|cit157","unstructured":"Ponticelli C Steroid withdrawal in organ transplant recipients [abstract no: 0351] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome, Italy 2000"},{"issue":"9268","key":"10.1002\/14651858.CD005015.pub4-BIB0157|cit158","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(00)04765-6","article-title":"Osteoporosis after organ transplantation","volume":"357","author":"Ponticelli","year":"2001","journal-title":"Lancet"},{"issue":"1-2","key":"10.1002\/14651858.CD005015.pub4-BIB0158|cit159","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0041-1345(00)02298-3","article-title":"Steroid withdrawal in renal transplant recipients","volume":"33","author":"Ponticelli","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"1-2","key":"10.1002\/14651858.CD005015.pub4-BIB0159|cit160","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0041-1345(97)83775-X","article-title":"A randomized study comparing cyclosporine alone vs double and triple therapy in renal transplants. The Italian Multicentre Study Group for Renal Transplantation (SIMTRe)","volume":"29","author":"Ponticelli","year":"1997","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD005015.pub4-BIB0160|cit161","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1681\/ASN.V84638","article-title":"A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation. Italian Multicentre Study Group for Renal Transplantation (SIMTRe)","volume":"8","author":"Ponticelli","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0162|cit162","unstructured":"Tarantino A Italian Multicentre Study Group for Renal Transplantation (SIMTRe) Is cylosporine (CsA, Sandimmun) monotherapy an effective and safe immunosuppressant in renal transplant recipients? [abstract] 16th Annual Meeting. American Society of Transplant Physicians (ASTP); 1997 May 10-14; Chicago (IL) 1997 128"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0041-1345(98)00407-2","article-title":"A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation: results at 7 years","volume":"30","author":"Tarantino","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD005015.pub4-BIB0164|cit164","first-page":"A250","article-title":"Long-term results of a randomized trial of 3 cyclosporine (CSA) regimens in cadaveric kidney allografts (TXC) [abstract]","volume":"15","author":"Tarantino","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0165|cit165","first-page":"280-1A","article-title":"The CONTROL STUDY: enhanced achievement of NKF-K\/DOQITM bone metabolism and disease targets using cinacalcet HCI (SensiparTM) [abstract no: F-PO986]","volume":"15","author":"Reed","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005015.pub4-BIB0166|cit166","first-page":"199","article-title":"Immunosuppression without maintenance steroids prevents decline of bone mineral density following renal transplantation [abstract]","volume":"3","author":"Rigotti","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.trim.2009.04.003","article-title":"Clinical rejection and persistent immune regulation in kidney transplant patients","volume":"21","author":"Hendrikx","year":"2009","journal-title":"Transplant Immunology"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.0306-5251.2003.01882.x","article-title":"Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids","volume":"56","author":"Hesselink","year":"2003","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005015.pub4-BIB0169|cit169","first-page":"482","article-title":"Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids [abstract no: 1290]","volume":"3","author":"Hesselink","year":"2003","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0170|cit170","unstructured":"Ter Meulen CG van Riemsdijk IC Hene RJ Christiaans MHL van Gelder T Hilbrands LB A prospective randomized trial comparing steroid-free immunosuppresion with limited steroid exposure on bone mineral density in the first year after renal transplantation [abstract no: 0344] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (FL) 2002"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1523-1755.2003.00116.x","article-title":"Decreased renal excretion of soluble interleukin-2 receptor alpha after treatment with daclizumab","volume":"64","author":"ter Meulen","year":"2003","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00198-004-1628-z","article-title":"The influence of corticosteroids on quantitative ultrasound parameters of the calcaneus in the 1st year after renal transplantation","volume":"16","author":"ter Meulen","year":"2005","journal-title":"Osteoporosis International"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0173|cit173","first-page":"101","article-title":"No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study","volume":"78","author":"ter Meulen","year":"2004","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0174|cit174","unstructured":"ter Meulen CG van Riemsdijk IC Hene RJ Christiaans MHL van Gelder T Hilbrands LB A prospective randomized trial comparing steroid-free immunosuppression with limited steroid exposure on bone mineral density in the first year after renal transplantation [abstract no: 0344] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (FL) 2002"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD005015.pub4-BIB0175|cit175","first-page":"578","article-title":"Steroid withdrawal at three days after renal transplantation with anti IL-2 receptor therapy: a prospective randomized multicenter trial [abstract no: 1529]","volume":"4","author":"Gelder","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005015.pub4-BIB0176|cit176","first-page":"171","article-title":"Anti-CD25 prophylaxis allows steroid-free renal transplantation in tacrolimus-based immunosuppression [abstract no: 133]","volume":"2","author":"Riemsdijk","year":"2002","journal-title":"American Journal of Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0041-1345(02)02987-1","article-title":"Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation","volume":"34","author":"Boots","year":"2002","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0178|cit178","unstructured":"Budde K Salmela K Pascual J Rigotti P THOMAS Study Group Steroid-withdrawal in tacrolimus-treated renal transplant recipients: results of a 3-year follow-up study [abstract no: 221] 3rd International Congress on Immunosuppression; 2004 Dec 8-11; San Diego (CA) 2004"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005015.pub4-BIB0179|cit179","first-page":"190","article-title":"Reduction of high cholesterol levels by early withdrawal of steroids from a tacrolimus-based triple regimen [abstract no: 206]","volume":"2","author":"Jindal","year":"2002","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD005015.pub4-BIB0180|cit180","first-page":"576","article-title":"Long-term efficacy and safety of steroid-withdrawal in tacrolimus treated renal transplant recipients: results of a 3 year follow-up [abstract no: 1524]","volume":"4","author":"Pascual","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.tp.0000225806.80890.5e","article-title":"Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant","volume":"82","author":"Pascual","year":"2006","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0041-1345(02)03082-8","article-title":"Patients with high cholesterol levels benefit most from early withdrawal of corticosteroids","volume":"34","author":"Rigotti","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0041-1345(02)03032-4","article-title":"Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study","volume":"34","author":"Squifflet","year":"2002","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0184|cit184","unstructured":"Van Hoof JP Salmela K Budde K Pascual J Rigotti P Lang P Long-term efficacy and safety of steroid-withdrawal in tacrolimus-treated patients: results of a long-term follow-up study in renal transplant recipients [abstract no: 99] 11th Congress of the European Society for Transplantation (ESOT); 2003 Sep 20-24; Venice, Italy 2003"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-6143.2004.00638.x","article-title":"Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial","volume":"5","author":"Vanrenterghem","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005015.pub4-BIB0186|cit186","first-page":"920A","article-title":"First, large, prospective study of a controlled withdrawal of steroids or MMF following three months of tacrolimus\/MMF\/steroid therapy [abstract no: A4809]","volume":"12","author":"Hooff","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0187|cit187","unstructured":"van Hooff JP European Tacrolimus\/MMF Transplantation Study Group Effect of controlled steroid withdrawal on glucose levels in a tacrolimus-based immunosuppression regimen [abstract no: P-69] 3rd International Congress on Immunosuppression; 2004 Dec 8-11; San Diego (CA) 2004"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005015.pub4-BIB0188|cit188","first-page":"44","article-title":"Effects of different steroid dosages on bone mineral density and body composition in renal transplant patients [abstract]","volume":"17","author":"Ham","year":"1998","journal-title":"Clinical Nutrition"},{"issue":"Sept","key":"10.1002\/14651858.CD005015.pub4-BIB0189|cit189","first-page":"711A","article-title":"The influence of early steroid withdrawal on body composition in renal transplant patients [abstract]","volume":"11","author":"Ham","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1432-2277.2003.tb00268.x","article-title":"The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients","volume":"16","author":"Ham","year":"2003","journal-title":"Transplant International"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD005015.pub4-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00007890-200407271-00779","article-title":"Simvastatin for prevention of bone loss following renal transplantation [abstract no: P284]","volume":"78","author":"Vasquez","year":"2004","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005015.pub4-BIB0192|cit192","first-page":"495","article-title":"A steroid-free immunosuppressive regimen of daclizumab, tacrolimus and MMF prevents loss of bone mass following renal transplantation [abstract]","volume":"18","author":"Zaoui","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD005015.pub4-BIB0193|cit193","first-page":"271A","article-title":"A prospective randomized controlled study of cholecalciferol supplementation in kidney transplant recipients- preliminary results at 30 months [abstract no: TH-PO766]","volume":"27","author":"Jorge","year":"2016","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD005015.pub4-BIB0194|cit194","first-page":"339","article-title":"A prospective and randomized trial of zoledronic acid to prevent bone loss in the first year after kidney transplantation. [abstract no: TH-PO923]","volume":"28","author":"Marques","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1681\/ASN.2018060656","article-title":"A randomized trial of zoledronic acid to prevent bone loss in the first year after kidney transplantation","volume":"30","author":"Marques","year":"2019","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0196|cit196","unstructured":"David-Neto E Zoledronic acid to prevent bone loss after kidney transplantation www.clinicaltrials.gov\/ct2\/show\/NCT01675089"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005015.pub4-BIB0197|cit197","first-page":"185","article-title":"Proteinuria in kidney transplant recipients: Prevalence in a national cohort and study design of the effect of paricalcitol for reduction of proteinuria [abstract no: RO-204]","volume":"24","author":"Arnol","year":"2011","journal-title":"Transplant International"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD005015.pub4-BIB0198|cit198","first-page":"S214","article-title":"Paricalcitol versus placebo for reduction of proteinuria in kidney transplant recipients: a double-blind, randomized controlled trial [abstract]","volume":"100","author":"Arnol","year":"2016","journal-title":"Transplantation"},{"issue":"13","key":"10.1002\/14651858.CD005015.pub4-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5414\/CNP88FX26","article-title":"Effects of paricalcitol on biomarkers of inflammation and fibrosis in kidney transplant recipients: results of a randomized controlled trial","volume":"88","author":"Oblak","year":"2017","journal-title":"Clinical Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD005015.pub4-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/tri.13323","article-title":"Paricalcitol versus placebo for reduction of proteinuria in kidney transplant recipients: a double-blind, randomized controlled trial","volume":"31","author":"Oblak","year":"2018","journal-title":"Transplant International"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.transproceed.2018.01.055","article-title":"Calcitriol reduces albuminuria and urinary angiotensinogen level in renal transplant recipients","volume":"50","author":"Tiryaki","year":"2018","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0202|cit202","unstructured":"Larsen J Vitamin D replacement after kidney transplant www.clinicaltrials.gov\/ct2\/show\/NCT00748618"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0203|cit203","unstructured":"Markell M Pilot study: Effects of hectorol (doxercalciferol) vitamin D replacement on proteinuria, PTH level and bone turnover in stable kidney transplant recipients: a single-blind, placebo-controlled study in patients receiving 25-oh vitamin D3 www.clinicaltrials.gov\/ct2\/show\/NCT00889629"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0204|cit204","unstructured":"Nickolas T A comparative trial of calcitriol versus placebo for the preservation of bone mass and strength after kidney transplantation www.clinicaltrials.gov\/ct2\/show\/NCT02224144"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0205|cit205","first-page":"19","article-title":"Influence of high-dose vitamin D3 therapy on calcitriol levels in vitamin-D-deficient kidney transplant recipients: preliminary results of a randomized controlled trial [abstract]","volume":"4","author":"Thiem","year":"2011","journal-title":"Austrian Journal of Clinical Endocrinology & Metabolism"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005015.pub4-BIB0206|cit206","first-page":"303","article-title":"Treatment of vitamin D deficiency and its impact on albumin excretion in kidney transplant recipients: preliminary results of a randomized controlled trial [abstract no: P-303]","volume":"24","author":"Thiem","year":"2011","journal-title":"Transplant International"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005015.pub4-BIB0207|cit207","first-page":"289","article-title":"Vitamin D for improving the outcome after kidney transplantation: rationale, design, and baseline characteristics of the participants of the VITA-D randomized controlled trial [abstract no: P520]","volume":"26","author":"Thiem","year":"2013","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0208|cit208","first-page":"36","article-title":"VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome","volume":"10","author":"Thiem","year":"2009","journal-title":"Trials [Electronic Resource]"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005015.pub4-BIB0209|cit209","first-page":"iii269","article-title":"Vita-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: preliminary report of a RCT to evaluate the post-transplant outcome [abstract no: Sa673]","volume":"3","author":"Thiem","year":"2010","journal-title":"NDT Plus"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0210|cit210","first-page":"430","article-title":"VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial","volume":"15","author":"Courbebaisse","year":"2014","journal-title":"Trials [Electronic Resource]"},{"issue":"7","key":"10.1002\/14651858.CD005015.pub4-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1047-2797(01)00226-5","article-title":"Hospitalizations for fractures after renal transplantation in the United States","volume":"11","author":"Abbott","year":"2001","journal-title":"Annals of Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","article-title":"Intermittent etidronate therapy to prevent corticosteroid induced osteoporosis","volume":"337","author":"Adachi","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000187765","article-title":"Loss of regional bone mineral density in the first 12 months following renal transplantation","volume":"66","author":"Almond","year":"1994","journal-title":"Nephron"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0214|cit214","unstructured":"Baker R Jardine A MacTier R How do the KDIGO Clinical Practice Guidelines on the care of kidney transplant recipients apply to the UK? www.renal.org\/wp-content\/uploads\/2017\/06\/management-of-the-kidney-transplant-recipient-in-the-uk.pdf"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0215|cit215","doi-asserted-by":"crossref","unstructured":"Baker RJ Mark PB Patel RK Stevens KK Palmer N Renal Association Clinical Practice Guideline. Post-operative care in the kidney transplant recipient www.renal.org\/wp-content\/uploads\/2017\/06\/final-post-operative-care-guideline.pdf","DOI":"10.1186\/s12882-017-0553-2"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1359\/jbmr.0809010","article-title":"Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial","volume":"24","author":"Brown","year":"2009","journal-title":"Journal of Bone & Mineral Research"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1111\/j.1440-1797.2010.01233.x","article-title":"Nutritional interventions for the prevention of bone disease in kidney transplant recipients","volume":"15 Suppl 1","author":"Chadban","year":"2010","journal-title":"Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711320307","article-title":"Diphosphonates inhibit bone resorption by macrophages in vitro","volume":"132","author":"Chambers","year":"1980","journal-title":"Journal of Pathology"},{"issue":"4","key":"10.1002\/14651858.CD005015.pub4-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group","volume":"109","author":"Chesnut","year":"2000","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2008.09.021","article-title":"A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis","volume":"53","author":"Chonchol","year":"2009","journal-title":"American Journal of Kidney Diseases"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00198-004-1614-5","article-title":"Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies","volume":"15","author":"Nijs","year":"2004","journal-title":"Osteoporosis International"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0223|cit223","first-page":"157","article-title":"In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferation","volume":"47","author":"Vries","year":"1982","journal-title":"Immunology"},{"issue":"4","key":"10.1002\/14651858.CD005015.pub4-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00007890-200208270-00011","article-title":"Bone mineral density and fracture prevalence in long-term kidney graft recipients","volume":"74","author":"Durieux","year":"2002","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD005015.pub4-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/ndt\/gfr169","article-title":"Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement","volume":"26","author":"Heemann","year":"2011","journal-title":"Nephrology Dialysis and Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-199609150-00002","article-title":"Influence of macrophage depletion on bacterial translocation and rejection in small bowel transplantation","volume":"62","author":"Fryer","year":"1996","journal-title":"Transplantation"},{"issue":"7650","key":"10.1002\/14651858.CD005015.pub4-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2265.1994.tb03020.x","article-title":"Continuous combined oestrogen\/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis","volume":"40","author":"Grey","year":"1994","journal-title":"Clinical Endocrinology"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/00007890-199410270-00009","article-title":"Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients","volume":"58","author":"Grotz","year":"1994","journal-title":"Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD005015.pub4-BIB0230|cit230","first-page":"2096","article-title":"Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients","volume":"10","author":"Grotz","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/jcem-52-1-111","article-title":"Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man","volume":"52","author":"Hahn","year":"1981","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"11","key":"10.1002\/14651858.CD005015.pub4-BIB0232|cit232","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008327.pub2","article-title":"Interventions for metabolic bone disease in children with chronic kidney disease","author":"Hahn","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6 Suppl 6","key":"10.1002\/14651858.CD005015.pub4-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1053\/ajkd.2001.28925","article-title":"Long-term kidney transplant survival","volume":"38","author":"Hariharan","year":"2001","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1034\/j.1399-0012.2000.140503.x","article-title":"Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease","volume":"14","author":"Heaf","year":"2000","journal-title":"Clinical Transplantation"},{"issue":"7414","key":"10.1002\/14651858.CD005015.pub4-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0236|cit236","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.5650090102","article-title":"Changes in bone mass early after kidney transplantation","volume":"9","author":"Horber","year":"1994","journal-title":"Journal of Bone & Mineral Research"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0238|cit238","first-page":"1548","article-title":"Clinical implication of hormone treatment in postmenopausal kidney transplants","volume":"28","author":"Hung","year":"1996","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"10.1002\/14651858.CD005015.pub4-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/01.TP.0000092523.30277.13","article-title":"Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate","volume":"76","author":"Jeffrey","year":"2003","journal-title":"Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","article-title":"Rapid loss of vertebral mineral density after renal transplantation","volume":"325","author":"Julian","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1302\/0301-620X.86B3.14300","article-title":"The effects of calcitonin on acute bone loss after pertrochanteric fractures","volume":"86","author":"Karachalios","year":"2004","journal-title":"Journal of Bone & Joint Surgery - British Volume"},{"issue":"113","key":"10.1002\/14651858.CD005015.pub4-BIB0242|cit242","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney International - Supplement"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0243|cit243","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9 Suppl 3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","journal-title":"American Journal of Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","article-title":"KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD)","volume":"55","author":"Uhlig","year":"2010","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.ajkd.2010.05.004","article-title":"Canadian Society of Transplantation and Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"56","author":"Knoll","year":"2010","journal-title":"American Journal of Kidney Diseases"},{"issue":"10","key":"10.1002\/14651858.CD005015.pub4-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1210\/jc.2014-1469","article-title":"No association between BMD and prevalent vertebral fractures in liver transplant recipients at time of screening for transplantation","volume":"99","author":"Krol","year":"2014","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/jbmr.2214","article-title":"Longitudinal changes in BMD and fracture risk in orthotopic liver transplant recipients not using bone-modifying treatment","volume":"29","author":"Krol","year":"2014","journal-title":"Journal of Bone & Mineral Research"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrneph.2009.192","article-title":"Bone disease after renal transplantation","volume":"6","author":"Malluche","year":"2010","journal-title":"Nature Reviews Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.V1161093","article-title":"High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation","volume":"11","author":"Monier-Faugere","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"19","key":"10.1002\/14651858.CD005015.pub4-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD005015.pub4-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/00007890-199905150-00004","article-title":"Increased fracture rate in diabetes mellitus and females after renal transplantation","volume":"67","author":"Nisbeth","year":"1999","journal-title":"Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0252|cit252","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00007890-200208150-00012","article-title":"Risk factors for fractures in kidney transplantation","volume":"74","author":"O'Shaughnessy","year":"2002","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0253|cit253","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"Journal of Bone & Mineral Research"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(96)90138-9","article-title":"Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study","volume":"28","author":"Pichette","year":"1996","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0255|cit255","unstructured":"Raggi P Burke S Chasen-Taber S Chertow G Holzer H Bommer J Sevelamer preserves trabecular bone mineral density [abstract] 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal 2004 103 4"},{"issue":"11","key":"10.1002\/14651858.CD005015.pub4-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/archinte.1996.00440100065008","article-title":"Testosterone therapy in glucocorticoid-treated men","volume":"156","author":"Reid","year":"1996","journal-title":"Archives of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD005015.pub4-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/art.1780310805","article-title":"Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis","volume":"31","author":"Sambrook","year":"1988","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0258|cit258","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD005015.pub4-BIB0259|cit259","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Deeks JJ Glasziou P Guyatt GH Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD005015.pub4-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.semnephrol.2003.08.012","article-title":"Bone disease after kidney transplantation","volume":"24","author":"Sprague","year":"2004","journal-title":"Seminars in Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1681\/ASN.V132551","article-title":"Calcium metabolism and skeletal problems after transplantation","volume":"13","author":"Torres","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00198-003-1532-y","article-title":"Long-term fracture risk following renal transplantation: a population based study","volume":"15","author":"Vautour","year":"2004","journal-title":"Osteoporosis International"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(99)70414-2","article-title":"Incidence and long-term cost of steroid-related side effects after renal transplantation","volume":"33","author":"Veenstra","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/tri.12691","article-title":"Bisphosphonates for preventing bone disease in kidney transplant recipients: a meta-analysis of randomized controlled trials","volume":"29","author":"Versele","year":"2016","journal-title":"Transplant International"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-015-3465-7","article-title":"Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials","volume":"27","author":"Wang","year":"2016","journal-title":"Osteoporosis International"},{"issue":"6","key":"10.1002\/14651858.CD005015.pub4-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2215\/CJN.01510506","article-title":"Bone disease after renal transplantation","volume":"1","author":"Weisinger","year":"2006","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"5","key":"10.1002\/14651858.CD005015.pub4-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolff","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD005015.pub4-BIB0268|cit268","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005015","article-title":"Interventions for preventing bone disease in kidney transplant recipients","author":"Palmer","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005015.pub4-BIB0269|cit269","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005015.pub2","article-title":"Interventions for preventing bone disease in kidney transplant recipients","author":"Palmer","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005015.pub4-BIB0270|cit270","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2004.12.007","article-title":"Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials","volume":"45","author":"Palmer","year":"2005","journal-title":"American Journal of Kidney Diseases"},{"issue":"3","key":"10.1002\/14651858.CD005015.pub4-BIB0271|cit271","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005015.pub3","article-title":"Interventions for preventing bone disease in kidney transplant recipients","author":"Palmer","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005015.pub4\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T09:16:14Z","timestamp":1679303774000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005015.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":271,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005015.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]}}}